Inhibition of the autocrine IL6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+breast cancers

被引：0
|
作者：
Silva, J.
Rodriguez-Barrueco, R.
Yu, J.
Kalinsky, K.
Maurer, M.
Califano, A.
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Columbia Univ, Nyc, NY USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-PD3-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD3-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The retinoid X receptor agonist MSU42011 enhances efficacy of anti-PD1 therapy in a HER2+breast cancer model through a CD4-IL12 axis
    Leal, Ana Sofia
    Liby, Karen T.
    CANCER RESEARCH, 2024, 84 (06)
  • [42] GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
    Jingjing Liu
    Lei Liu
    Ernesto Yagüe
    Qianxi Yang
    Teng Pan
    Hui Zhao
    Yunhui Hu
    Jin Zhang
    Breast Cancer Research and Treatment, 2019, 174 : 65 - 78
  • [43] Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?
    Britschgi, Adrian
    Radimerski, Thomas
    Bentires-Alj, Mohamed
    DRUG RESISTANCE UPDATES, 2013, 16 (3-5) : 68 - 72
  • [44] GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
    Liu, Jingjing
    Liu, Lei
    Yague, Ernesto
    Yang, Qianxi
    Pan, Teng
    Zhao, Hui
    Hu, Yunhui
    Zhang, Jin
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (01) : 65 - 78
  • [45] CDK4/6 inhibition and endocrine therapy (ET) in the HER2-enriched subtype (HER2-E) in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer (ABC): A retrospective analysis of real-world data
    Martinez-Saez, O.
    Tolosa, P.
    Sanchez De Torre, A.
    Pascual, T.
    Braso-Maristany, F.
    Rodriguez Hernandez, A.
    Parrilla, L.
    Roncero, A. M.
    Ruano, Y.
    Chic, N.
    Schettini, F.
    Laguna, J. C.
    Sanfeliu Torres, E.
    Gonzalez-Farre, B.
    Vidal, M.
    Adamo, B.
    Guillen Sacoto, M. C.
    Munoz, M.
    Prat, A.
    Ciruelos, E. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S30 - S30
  • [46] Nifuroxazide Mitigates Angiogenesis in Ehlrich's Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling
    El-Sherbiny, Mohamed
    El-Sayed, Rehab M.
    Helal, Mohamed A.
    Ibrahiem, Afaf T.
    Elmahdi, Hoda S.
    Eladl, Mohamed Ahmed
    Bilay, Shymaa E.
    Alshahrani, Asma M.
    Tawfik, Mona K.
    Hamed, Ziad E.
    Mohamed, Amany O.
    Zaitone, Sawsan A.
    MOLECULES, 2021, 26 (22):
  • [47] Chlorogenic Acid Alleviates Chronic Stress-Induced Duodenal Ferroptosis via the Inhibition of the IL-6/JAK2/STAT3 Signaling Pathway in Rats
    Zhao, Yuan
    Wang, Chuqiao
    Yang, Tianyuan
    Wang, Hui
    Zhao, Shuping
    Sun, Ning
    Chen, Yongping
    Zhang, Haiyang
    Fan, Honggang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2022, 70 (14) : 4353 - 4361
  • [48] JAK2/STAT3 and TrkA pathways are frequently co-activated in triple-negative and HER2-enriched breast cancers and the co-activation correlates with an increased potential of metastasis.
    Regua, Angelina T.
    Aguayo, Noah R.
    Abu Jalboush, Sara
    Doheny, Daniel L.
    Manore, Sara G.
    Zhu, Dongqin
    Wong, Grace L.
    Arrigo, Austin
    Wagner, Calvin J.
    Yu, Yang
    Baylon, Karen
    Thomas, Alexandra
    Chan, Michael D.
    Ruiz, Jimmy
    Jin, Guangxu
    Strowd, Roy E.
    Sun, Peiqing
    Metheny-Barlow, Linda J.
    Lin, Jiayuh
    Lo, Hui-Wen
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
    Shi, Jindong
    Feng, Jingjing
    Xie, Juan
    Mei, Zhoufang
    Shi, Tianyun
    Wang, Shengmei
    Du, Yong
    Yang, Gong
    Wu, Yougen
    Cheng, Xiaojiao
    Li, Shanqun
    Zhu, Liming
    Yang, Chung S.
    Tu, Shuiping
    Jie, Zhijun
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
    Jindong Shi
    Jingjing Feng
    Juan Xie
    Zhoufang Mei
    Tianyun Shi
    Shengmei Wang
    Yong Du
    Gong Yang
    Yougen Wu
    Xiaojiao Cheng
    Shanqun Li
    Liming Zhu
    Chung S. Yang
    Shuiping Tu
    Zhijun Jie
    Scientific Reports, 7
12345